Intuniv is labelled for kids. Do adults who cannot take stimulants still get guanfacine XR in Canada?

Intuniv XR is labelled for ADHD in children and adolescents, not in adults, and that gap is the starting point rather than a rumour. The Canadian product monograph indicates guanfacine XR for ADHD in ages 6 to 17 as monotherapy or as an adjunct to stimulants; it is not indicated in people over 18. Adults who cannot take stimulants may still be prescribed guanfacine XR in some clinics, but that use is off-label relative to Health Canada labelling. If the change is persistent, distressing, or affecting daily functioning, bring a brief timeline to the prescribing clinician rather than changing the dose independently. Related reading: https://www.fastreat.com/en/blogs/adhd-medication References: https://assets-dam.takeda.com/image/upload/LOC/en-ca/Products/intuniv-xr-pm-en.pdf https://www.caddra.ca/wp-content/uploads/CADDRA_ADHD-Medication-Chart_May2026.pdf https://www.caddra.ca/wp-content/uploads/Canadian-ADHD-Practice-Guidelines-4.1-January-6-2021.pdf